MedPath

Effect of Omega-3 Supplementation on Serum Level and Gene Expression of IGF-1and IGFBP-3 in Men With CVD.

Phase 4
Completed
Conditions
Cardiovascular Disease
Registration Number
NCT02092584
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

The aim of this study is the comparison between the effects of supplementation with omega 3 or placebo for 8 weeks in serum level of IGF-1 and IGFBP-3 and gene expression of IGF-1 in patients with cardiovascular disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
31
Inclusion Criteria
  • CVD patients 45- 65 years old, patients with ≥ 50% stenosis in at least one coronary angiogram demonstrated, body mass index in the range 18.5- 35, avoidance of dietary supplements, vitamins and herbal products at least 3 months before and throughout the intervention, willingness to participation,
Exclusion Criteria
  • people who have used omega 3 supplements in last 3 months, having chronic renal disease , GI disease, hepatobiliary diseases, hematological disorders, hypo- or hyperthyroidism, Smokers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Serum Total CholesterolChange from baseline at 2 months
Serum HDL-CChange frome baseline at 2 months
Serum LDL-CChange frome baseline at 2 months
Serum TGChange frome baseline at 2 months
Serum Fasting Blood Sugar(FBS)Change frome baseline at 2 months
Serum InsulinChange frome baseline at 2 months
Serum hsCRPChange frome baseline at 2 months
Serum Insulin Like Growth Factor-1(IGF-1)Change frome baseline at 2 months
Serum IGF binding protein 3(IGFBP-3)Change frome baseline at 2 months
Secondary Outcome Measures
NameTimeMethod
Gene Expression of IGF-1Change frome baseline at 2 months
Gene expression of IGFBP3change from baseline at 2 months

Trial Locations

Locations (1)

Tehran University of Medical Sciences

🇮🇷

Tehran, Iran, Islamic Republic of

Tehran University of Medical Sciences
🇮🇷Tehran, Iran, Islamic Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.